10x GenomicsNASDAQ: TXG

Results indicate strong potential to further expand resources and continue to extend mine life (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces assay results from the Company's ongoing drilling program at El Limón Guajes ("ELG") Underground. The results to date support Torex's target of extending the mine life of ELG Underground beyond 2028 by identifying new zones of higher-grade mineralization, expanding resources, and increasing reserves.

Researchers used Chromium Single Cell products and Xenium In Situ to profile how gene expression is spatially regulated during secondary palate formation PLEASANTON, Calif., June 27, 2024 /PRNewswire/ -- 10x Genomics, Inc.  (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that its Xenium In Situ platform was used in a study published in the Journal of Dental Research, offering novel insights into cellular mechanisms regulating the formation of the secondary palate.

PHILADELPHIA, PA / ACCESSWIRE / June 11, 2024 / Kaskela Law LLC announces that it is investigating 10x Genomics, Inc. (NASDAQ:TXG) on behalf of the company's stockholders. The investigation seeks to determine whether 10x Genomics and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's investors in connection with recent corporate actions.

Pipeline of high-quality targets systematically prioritized to unlock the full potential of Morelos (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - June 10, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) is pleased to provide detail on a multi-year exploration strategy for its highly prospective Morelos Property ("Morelos"), designed to generate incremental additions to mineral resources in the near term, generate at least one new discovery in the mid-term, and extend the mine life at Morelos in order to deliver stable production and cash flow well beyond 2033. Jody Kuzenko, President & CEO of Torex, stated: "Since 2021, our exploration strategy has been focused on shoring up the near-term production profile and identifying future sources of feed to fill the mill beyond 2027.

Report shines a spotlight on continued excellence in ESG performance and disclosure (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 21, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) today released its 2023 Responsible Gold Mining Report (the "Report") titled At the Heart of Who we Are, the Company's ninth annual disclosure of its Environmental, Social and Governance ("ESG") performance. The Report can be found on the Company's website at www.torexgold.com.

Examine 10x Genomics' (TXG) global revenue results and their impact on financial analysts' forecasts on Wall Street, as well as the stock's future potential.

10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Conference Call April 30, 2024 at 4:30 PM ET. Company Representatives: Cassie Corneau - Director of Investor Relations & Strategic Finance, Serge Saxonov - CEO & Co-Founder, Justin McAnear - CFO. Conference Call Participants: Mason Carrico - Stephens, Inc., Patrick Donnelly - Citigroup, Daniel Arias - Stifel Financial, Doug Schenkel - Wolfe Research, Dan Brennan - TD Cowen, Matt Larew - William Blair, Matthew Sykes - Goldman Sachs, Subbu Nambi - Guggenheim Partners, Michael Ryskin - Bank of America, Tejas Savant - Morgan Stanley, Luke Sergott - Barclays, Kyle Mikson - Canaccord Genuity. Operator: Good day and welcome to the 10x Genomics First Quarter 2024 Earnings Call. This call is being recorded.

The latest figures for 10x Genomics (TXG) provide an indication of the company's performance in the first quarter of 2024, but it could be beneficial to analyze certain key metrics in comparison to Wall Street projections and the previous year's results.

10x Genomics, Inc. (TXG) Q4 2023 Earnings Call Transcript